Across TCGA pan-cancer cohorts, VTRNA3-1P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated VTRNA3-1P data layer.
The strongest signal is observed in thymoma (THYM), where higher VTRNA3-1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated VTRNA3-1P expression acts as an unfavorable survival marker, although some lineages such as LUSC and SARC show a favorable association.
THYM, BLCA, and LUSC are the cancer types where VTRNA3-1P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.